Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck

Cesar A. Perez, Hunho Song, Luis E. Raez, Mark Agulnik, Tatyana A. Grushko, Allison Dekker, Kerstin Stenson, Elizabeth A. Blair, Olufunmilayo I. Olopade, Tanguy Y. Seiwert, Everett E. Vokes, Ezra E.W. Cohen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences